Apoptosis is a ubiquitous genetically encoded pathway that enables cells to undergo highly regulated death in response to specific signals. It has also been observed to occur as a consequence of distinct pathologies, and its deregulation can lead to autoimmune, cancer and neurodegenerative diseases (1). It is characterized by the activation of precise pathways leading to specific biochemical and morphological alterations, including changes in the intracellular ionic homeostasis, cell shrinkage, phosphatidylserine externalization, chromatin condensation, DNA degradation, membrane blebbing and apoptotic body formation (1,2). Fas ligand (FasL)-induced apoptosis by binding to its receptor Fas (CD95/Apo-1) has been reported to play a critical role in immune homeostasis. Fas receptormediated apoptosis has also been implicated in the pathogenesis of fulminant hepatitis, post-ischemic neuronal degeneration, traumatic brain injury and inflammatory lung diseases. Its deregulation is also associated with progression and metastasis of 1 http://www.jbc.org/cgi
Apoptosis is a ubiquitous genetically encoded pathway that enables cells to undergo highly regulated death in response to specific signals. It has also been observed to occur as a consequence of distinct pathologies, and its deregulation can lead to autoimmune, cancer and neurodegenerative diseases (1) . It is characterized by the activation of precise pathways leading to specific biochemical and morphological alterations, including changes in the intracellular ionic homeostasis, cell shrinkage, phosphatidylserine externalization, chromatin condensation, DNA degradation, membrane blebbing and apoptotic body formation (1, 2) . Fas ligand (FasL)-induced apoptosis by binding to its receptor Fas (CD95/Apo-1) has been reported to play a critical role in immune homeostasis. Fas receptormediated apoptosis has also been implicated in the pathogenesis of fulminant hepatitis, post-ischemic neuronal degeneration, traumatic brain injury and inflammatory lung diseases. Its deregulation is also associated with progression and metastasis of tumors and autoimmune lymphoproliferative syndrome (3) .
Glutathione (GSH) is the predominant low-molecular-weight thiol in animal cells. It participates in many cellular reactions, including antioxidant defense of the cell, drug detoxification, cell signaling, and has been reported to be necessary for the proliferation of several cells including lymphocytes (4) (5) (6) . A reduction in the intracellular GSH concentration ([GSH] i ) has been reported during cell death in response to different apoptotic stimuli, including death receptorinduced (7-10), stress-induced, (11) and druginduced cell death (12) . Several studies have shown a correlation between GSH efflux and the progression of apoptosis (13, 14) , and a recent report suggests that inhibition of GSH release in apoptosis is able to rescue cells from apoptosis (8) , however the precise mechanisms involved in GSH i loss have not been identified. Glutathione synthesis occurs intracellularly and its catabolism occurs by a series of both enzymatic and plasma membrane export mechanisms. Glutathione degradation occurs extracellularly, therefore the export of GSH and GSH-adducts is also an important step in its turnover (15) . To date, two GSH transporter families have been implicated in GSH efflux across the plasma membrane. These include the multidrug resistant protein (MRP), encoded by ABCC genes, subfamily of the ATP binding cassette transporters (ABC transporters); and the organic anion transporting polypeptide proteins (OATP), encoded by SLCO genes. During apoptosis, GSH i loss has been suggested to be mediated by activation of GSH active transport (7, 8, 11, 16) , however, neither the identity of the transport mechanism involved in GSH extrusion nor its relationship with the progression of apoptosis have been elucidated.
In the present work, we present evidence for the involvement of an organic anion exchange mechanism (a SLCO/OATP-like transporter) in the reduction of [GSH] i observed during FasLinduced apoptosis. Moreover, we show that the GSH i loss is a necessary step for the progression of the execution phase of the cell demise.
Experimental Procedures
Reagents -RPMI 1640, penicillin/streptomycin and heat inactivated Fetal Calf Serum were from GIBCO/Invitrogen Co. (Carlsbad, CA). Fas ligand (FasL) was from Kamiya Biomedical Company (Seattle, WA). MK571 was from BioMol (Plymouth, PA). 5-carboxyfluorescein diacetate (CFDA), 5 (and 6)-carboxy-2',7'-dichlorofluorescein (CDF) and monochlorobimane (mBCl) were from Molecular Probes Inc. (Eugene, OR). Cytofix/cytoperm kit, and the monoclonal antibodies PE-conjugated anti-active caspase 3, FITC-conjugated anti-PARP cleavage site specific and FITC-conjugated anti-MRP1 monoclonal antibody were from BD Biosciences (San Diego, CA). Anti-caspase-3 and 7, anti-BID, anti-PARP and anti-α-fodrin antibodies (mAb, human specific) were from Cell Signaling Technology Inc (Beverly, MA). All other reagents were from SIGMA/Aldrich (St. Louis, MO).
Cell culture and media-Jurkat cells, E6.1 clone (human leukemia) were obtained from American Tissue Culture Collection (Manassas, VA). Cells were cultured in RPMI 1640 medium containing 10% heat-inactivated fetal calf serum, 2 mM glutamine, 31 mg/l penicillin, and 50 mg/l streptomycin at 37 o C, 7% CO 2 atmosphere. Jurkat cells (5-7 x 10 5 cells/ml) were incubated with Fas ligand (FasL) for the time indicated for the induction of apoptosis. In the media containing high glutathione (GSH), NaCl was substituted with 25 mM L-glutathione, maintaining the same osmolarity of the media. For choline-or NMDGsubstituted medium, RPMI 1640 medium was initially made substituting NaCl for either choline chloride or NMDG. Additionally, choline bicarbonate and magnesium phosphate was used in place of sodium bicarbonate and sodium phosphate, respectively. Media osmolarity was measured on a Wescor 5500 vapor pressure osmometer (Logan, UT). [GSH tot ] -Quantitative, colorimetric determination of total intracellular glutathione concentration [glutathione] i , was measured using Bioxytech GSH-420 kit (OxisResearch, Portland, OR) following manufacturer's specifications. This method is based on the formation of a chromophoric thione, using 4-chloro-1-methyl-7-trifluoromethylquinolinum methylsulfate as chromogen, whose absorbance was measured at 420 nm on a DU650 spectrophotometer (Beckman, Fullerton, CA). The absorbance at 420 nm is linearly proportional to the concentration of glutathione. A calibration curve with provided calibrator solutions was performed for each experiment. For each sample, 2 x 10 7 cells/sample were used and total glutathione content was normalized to protein concentration for each sample. This method determines total intracellular glutathione [GSH tot ], i.e. both reduced (GSH) and oxidized forms (GSSG is reduced to GSH using tris(2-carboxyethyl)phosphine, TCEP). Results are expressed as a percentage of change in the intracellular GSH content versus control conditions.
Total intracellular glutathione determinations

Reduced (GSH) and oxidized (GSSG) glutathione
determinations -Cells were incubated with 250 µM L-(αS,5S)-α-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin) for 4h, to inhibit catabolism released GSH by the γ-Glutamyltransferase (GGT). Then, cells (2 x 10 7 cells/ml) were induced to undergo apoptosis with FasL in the presence of acivicin. Samples centrifuged and aliquots were taken for extracellular determinations. Pellets were resuspended in ice-cold phosphate-buffered saline (PBS), homogenized and kept frozen until use for intracellular determinations. The extracellular and intracellular GSH and GSSG concentrations were measured enzymatically using the GSH/GSSG-412 kit (Oxis Research, Portland, OR). Samples were prepared in 5% metaphosphoric acid to remove proteins, with or without 1-methyl-2-vinyl-pyridium trifluoromethane sulfonate, a GSHspecific scavenger. Ellman's reagent (5',5-dithiobis-2-nitrobenzoic acid) reacts with GSH to form a product with an absorption maximum at 412 nm. GSSG was determined using glutathione reductase and β-nicotinamide adenine dinucleotide phosphate (NADPH) to reduce GSSG to GSH followed by reaction with Ellman's reagent. Results are normalized to protein concentration for each sample.
Flow cytometry assay -FasL-induced apoptotic parameters were analyzed by flow cytometry using a BD LSR II flow cytometer and BD FACSDiva Software (Becton Dickinson, San Jose, CA) for data analysis, unless otherwise stated. Cells were analyzed at a cell density of 5 x 10 5 cells/ml, and in all cases ten thousand cells were analyzed. Fluorophores were diluted in dimethyl sulphoxide (DMSO) and preloaded at 37 o C, 7% CO 2 . In all cases, the final concentration of DMSO never exceeded 0.1%. When indicated, propidium iodide (PI) was added at a final concentration of 10 µg/ml to evaluate plasma membrane integrity. Sequential analysis of the distinct fluorophores was used and, unless otherwise indicated, cells with increased PI fluorescence were excluded during the analysis. For PI, cells were excited with an Argon 488 nm laser and emission was acquired with a 695/40 filter. Histograms and plots in all cases are representative of at least 3 different experiments. Changes in different morphological and biochemical parameters during apoptosis induced by FasL in Jurkat cells were determined as follows.
Changes in intracellular glutathione concentration, [GSH] i -For intracellular GSH (GSH i )
measurements, cells were preloaded 10 min with 10 µM mBCl, which forms blue-fluorescent adducts with intracellular glutathione (17, 18) . Immediately prior to flow cytometry examination PI was added. For mBCl, cells were excited with a Violet (UV) 405 laser and emission was acquired with a 440/40 filter. When indicated, mBCl fluorescence was plotted against changes in forward scatter, which was acquired by exciting the cells with an Argon 488 nm laser.
5-carboxyfluorescein (CF) efflux assay, for
functional assessment of multidrug resistance protein activity -Cells were incubated with 1 µM CFDA for 1 h at 37 °C then centrifuged and washed with CFDA-free medium. CFDA diffuses into cells where it is cleaved by intracellular esterases resulting in fluorescent carboxyfluorescein (CF), which is a substrate of ABCC/MRP transporters (19) . Cells were then resuspended in CFDA-free medium and allowed to efflux CFDA for the time indicated at 37 °C in the presence or absence of ABCC/MRP activity reversal agents. Immediately prior to flow cytometry examination PI was added. For CF-fluorescence, samples were excited using an Argon 488 laser with a 530/30 filter. Relative mRNA levels for ABCC/MRP and SLCO/OATP transporters were analyzed using a standard curve from 50 to 200 ng (5 concentrations) of cDNA input to obtain the threshold cycle, C T . This C T value is determined as the cycle number at which the reporter fluorescent emission increases above a threshold level (usually 10 times the standard deviation of the baseline) at a concentration of 50 ng of cDNA input. As control we used GAPDH, to correct for potential variation in RNA loading of amplification efficiency in each experiment. Data is expressed as the intercept C T values of each gene obtained from standard curves normalized against the GAPDH C T value (C T GAPDH / C T ). All samples were amplified simultaneously in triplicate in one assay run. For amplification efficiency validation, standard curve equation values are shown in Table  1 for each gene analyzed (i.e, each primer/probe set used). Table 1 shows the standard curve equation for each gene where the logarithm of each cDNA input concentration is plotted on the xaxis and the corresponding C T value on the y-axis. R 2 is calculated from the standard curve of 5 data pairs (0-200 ng). C T values greater than 40 indicate that mRNA levels were on the lower limit of detection and are not considered significant.
(and
Protein extraction and western immunoblotting -
Cells were pelleted, washed once with ice-cold PBS and lysed in buffer containing 20 mM TrisHCl, 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% Triton X-100 and protease inhibitors (Complete Mini protease cocktail, Roche, IN). Samples were sonicated, centrifuged, and the pellets discarded. Then, samples were assayed in a Beckman DU650 spectrophotometer for protein concentration using Biorad Protein Assay (BIORAD, Hercules, CA) and cell extracts were normalized to equal protein concentration. Loading buffer containing glycerol, sodium dodecyl sulfate (SDS), and bromophenol blue was added, and samples were denatured at 99 °C for 5 min. Protein extracts, 50 µg/sample, were separated by SDS-Polyacrilamide gel electrophoresis (PAGE) on 4-20% gradient polyacrylamide tris/glycine gels (Novex, Invitrogen, CA) and transferred to nitrocellulose. Membranes were blocked in Tris-buffered saline (TBS) containing 0.05% Tween and 10% nonfat dry milk for 1 h. Antibodies were diluted in TBS containing 0.05% Tween and 5% nonfat dry milk. Blots were incubated with the corresponding primary antibody (1:1000) overnight. Then, blots were incubated for 1 h with the corresponding horseradish peroxidase-linked secondary antibodies (Amersham Biosciences Corp., Piscataway, NJ) diluted 1:10000 in TBS containing 0.05% Tween and 0.5% nonfat dry milk. Blots were then visualized on film with the ECL chemiluminescent system. Blots were subsequently stripped using 65 mM Tris-HCl pH 6.7, 100 mM beta-mercaptoethanol, 2% SDS buffer and reprobed for α-tubulin to verify equal protein loading.
Statistical analysis -When indicated, significances of differences in mean values were calculated using the two-tailed Student s t-test. The number of experiments is indicated in each case in the legends of the figures
RESULTS
FasL-induced reduction in total intracellular glutathione concentration [GSH] i .-A reduction in
[GSH] i is a feature observed in apoptosis triggered by different stimuli, but the mechanisms involved in GSH i loss are not clear (21) . Apoptotic agents have also been reported to stimulate the generation of reactive oxygen species, particularly hydrogen peroxide (22, 23) , which might reduce [GSH] i by its oxidation to glutathione disulfide (GSSG). However, several reports have demonstrated the activation of an efflux transport mechanism for GSH extrusion rather than its oxidation to GSSG, underlies the decrease in [GSH] i (7, 8, 11, 16 Figure 1A , left panel) and dose-( Figure 1A ,
These results support the hypothesis that activation of an efflux transport mechanism underlies the decrease in [GSH] i .
Apoptosis is a stochastic phenomenon that can be explained by exponential kinetics, which suggests first, that the risk of cell death is constant, secondly, that cell death occurs randomly in time and, thirdly, that the death of one cell is independent of that of other cells (24) . Accordingly, kinetic and dose-dependent curves of the reduction in [GSH] i induced by FasL ( Figure  1A ) fit well with exponential decay curves (r 2 > 0.9), suggesting that the loss of GSH i correlates with the stochastic progression of cell death in Jurkat cells stimulated by FasL. To determine if the reduction in intracellular concentration occurs stochastically during FasL-induced apoptosis, we studied the reduction in [GSH] i by single cell analysis by flow cytometry. We simultaneously used the intracellular GSH (GSH i ) fluorophore mBCl and PI to evaluate for loss of membrane integrity. Histograms of mBCl fluorescence show that cells preloaded with the GSH dye had a high level of fluorescence, depicted as a single population of cells, reflecting the basal levels of GSH i ( Figure 1B , 0h panels). The fluorescence of Jurkat cells preloaded with mBCl was homogenously reduced after acute treatment with 1mM diethylmalate (DEM) and 200 µM DLbuthionine-(S,R)-sulphoximine (BSO), agents which induce GSH i depletion by inhibiting the gamma-glutamyl cysteine synthetase and by direct reduction of mitochondrial GSH, respectively. This treatment has been previously reported to efficiently deplete cells of glutathione from both cytosol and mitochondria (25) . Normal turnover of intracellular GSH in the presence of BSO (200µM) requires up to 24hrs of treatment to deplete intracellular GSH ( Figure  3A) . When a strong specific thiol-oxidant like DEM is added to the media, GSH depletion is accelerated as seen in control experiments in Figure 1C . In contrast, GSH loss by FasL observes a dose dependent component, and at saturating concentrations of it (100ng/ml,) depletes Jurkat cells from intracellular GSH within a half-life of 4 hr ( Figure 1D , and 3B). Treatment with BSO (4hr) marginally reduced the GSH i content of control cells ( Figure 3B ). However, in the presence of BSO, FasL-induced GSH loss remained unaffected. Thus, it is unlikely that GSH depletion during FasL -induced apoptosis is mediated by synthesis inhibition and normal turnover.
The multidrug resistance proteins (ABCC/MRP) do not participate in the reduction of [GSH] i
induced by FasL. -To date two different kinds of glutathione efflux transporters have been identified at the molecular level in mammalian cells (26) (27) (28) (29) . They include the multidrug resistance proteins ABCC/MRP, and the members of the organic anion transporting polypeptide proteins, SLCO/OATP. Thus, we sought to determine which of these transport proteins was involved in GSH efflux during FasL-induced apoptosis. Human leukemia cell lines have been reported to express high levels of MRP proteins, and previous studies have suggested that Jurkat cells express high levels of the multidrug resistance protein 1 (ABCC1/MRP-1) (30, 31) , but the presence of other subtypes of ABCC/MRP transporters has not yet been assessed. By means of RT-PCR we were able to detect of several members of the ABCC/MRP protein family, including ABCC1/MRP-1, ABCC2/MRP-2, ABCC4/MRP-4, and ABCC5/MRP-5 ( Table 1) . The ABCC6/MRP-6 and ABCC7/MRP-7 genes were observed at the detection limit of the system. We also analyzed protein expression levels of the ABCC/MRP transporters in Jurkat cells. Immunolabeling analysis of fixed Jurkat cells showed an uniform increased level of fluorescence for cells stained with a FITC conjugated mAb against an intracellular epitope of ABCC1/MRP-1, compared to non-stained cells ( Figure 4A ), corroborating that the protein expression of ABCC1/MRP-1 in Jurkat cells is homogeneous. The functional expression of ABCC/MRP transporters was also supported by CF-release experiments. Carboxy-dichlorofluorescein release assay is widely used to study the activity of ABCC/MRP proteins (32) . Multidrug resistance protein-mediated transport of organic substrates, like CF, has been reported to be coupled to the extrusion of GSH, and both are inhibited by a wide variety of drug reversal agents (15, (27) (28) (29) (32) (33) (34) . We observed that preloaded Jurkat cells actively extrude CF ( Figure 4B ), and that its release was significantly inhibited by the drug reversal agents probenecid and MK571, being most sensitive to MK571. This pharmacological profile is consistent with the participation of ABCC/MRP proteins in the extrusion of CF. Moreover, 50 µM BSO pretreatment (overnight) of Jurkat cells, which reduces [GSH] i without reducing cell viability (not shown), significantly reduced CF efflux ( Figure  4B ). This result supports the role of GSH i as a necessary cofactor in ABCC/MRP-mediated CF extrusion. Carboxyfluorescein has also been shown to be extruded by other members of the ABC transporter family, particularly by the ABCA1 (P-glycoprotein), whose activity may account for the active extrusion of CF. However, we did not detect significant mRNA levels or an immunolabeling signal for ABCA1 in Jurkat cells (data not shown). We also studied the effect of MK571 and probenecid on GSH efflux induced by FasL. Intracellular GSH loss induced by FasL was stimulated by MK571 and probenecid ( Figure 4C  and D Another characteristic of the GSH transport mediated by SLCO/OATP proteins is that the driving force for the net GSH export is determined by the electrochemical gradient of GSH across the plasma membrane (7, 15) . Glutathione is 90% freely distributed in the cytosol where it is present in concentrations up to 10 mM in animal cells, whereas in plasma, concentrations are approximately 0.01 mM, and in cell culture medium they are around 0.003 mM. Moreover, because GSH is negatively charged at physiological pH, there is a large intracellular negative potential of -30 to -60 mV that facilitates its extrusion. Thus, increasing the extracellular GSH concentration decreases the driving force of GSH extrusion and reduces net GSH efflux mediated by SLCO/OATP transporters. It is important to mention, that high extracellular GSH stimulates SLCO/OATP efflux of GSH i , however, net reduction of [GSH] i is prevented by its exchange for extracellular GSH. As shown in figure 5A , an isosmotic increase of 25 mM in the extracellular concentration of GSH prevented GSH i loss during FasL induced apoptosis. These results were also corroborated biochemically by analyzing the changes in [glutathione] i . Figure 5C shows that the reduction in the total intracellular glutathione content induced by FasL is enhanced by MK571. High extracellular GSH concentrations not only prevented the loss of [GSH tot ], but also its stimulation by MK571. These data suggest that both the stimulation of GSH efflux by OA -and its inhibition by high GSH medium act on the same GSH transport mechanism activated during apoptosis. Together these results, point to the participation of SLCO/OATP proteins rather than ABCC/MRP transporters in GSH i loss induced during FasL-induced apoptosis.
We observed that glutathione depletion in Jurkat cells upon FasL stimulation was mediated by a reduction in its [GSH tot ]. To clarify if glutathione was getting effluxed in its reduced (GSH) or oxidized (GSSG) form, we next analyzed changes in both extracellular and intracellular concentrations of GSH and GSSG. This was performed enzimatically using DTNB as chromogen (Ellman's reagent). Table 2 shows that FasL induced the accumulation of extracellular GSH, GSH e , concomitant with a decrease in GSH i . In accordance to the hypothesis of an SLCO/OATP-like exchanger involved in GSH loss, MK571 enhanced both GSH e accumulation and GSH i depletion. Intracellular GSH i depletion was prevented in the presence of high extracellular GSH medium. A small, but significant accumulation of GSSG e was also observed (Table  2) , which was also stimulated by MK571. However, intracellular GSSG formation was not detected upon FasL stimuli. Thus, the increase in GSSG e might be ascribed to extracellular GSH auto-oxidation after its extrusion. Figure 6A ). We observed that the first population of cells with a reduction in [GSH] i showed a high degree of OA -uptake activity. Additionally we observed that in the presence of CDF, control cells exhibited a significant increase in fluorescence compared to cells in the absence of CDF (blank). This data suggests that there is a basal OA -uptake activity in the absence of FasL. Carboxy-dichlorofluorescein uptake in control cells was enhanced by the presence of MK571 ( Figure 6B ). This observation can be explained by the action of MK571 on the inhibition of CDF release from cells mediated by ABCC/MRP proteins ( Figure 4B ). In accordance with the observations for GSH i loss, OA -uptake was stimulated by MK571 and inhibited by high extracellular GSH medium ( Figure 6B ). Uptake of non-permeable fluorescein derivates has been ascribed to the activation not only of SLCO/OATP transporters but also of the family of organic anion transporters, SLC22A/OAT (20, 42) . Accordingly, fluorescein-derivatives uptake by SLC22A/OAT transporters has been reported inhibited by paminohippuric (PAH) acid and coupled to the Na + -gradient across the plasma membrane (42, 43) . As shown in Figure 6C , FasL-induced OA -uptake was not affected neither by addition of PAH nor by Na + -substituted media suggesting that it was not mediated by SLC22A/OAT transporters. These data support the hypothesis of a common mechanism for both GSH efflux and OA -uptake , with similar characteristics of a SLCO/OATP-like transporter (GSH/OA -exchanger).
FasL-induced GSH
Glutathione transport modulates the progression of the execution phase of apoptosis-
The role of GSH i loss in the progression of apoptosis has not been clearly elucidated. Thus, we analyzed the relationship between GSH transport and the progression of the apoptotic cascade. Figure 7A shows that inhibition of GSH efflux by high extracellular GSH medium inhibited the cleavage of the execution caspases 3 and 7 during FasLinduced apoptosis. The cleavage of execution caspase substrates PARP and α-fodrin was also inhibited by the presence of high extracellular GSH medium ( Figure 7B ). Moreover, transstimulation of the GSH efflux transport by MK571 also increased the degree of caspase 3 and 7 cleavage as well as the cleavage of their substrates, PARP and α-fodrin ( Figure 7C and 7D). Cleavage of execution caspases and of their substrates was also shown to be stimulated by probenecid, taurocholic acid and estrone sulfate (not shown), thus suggesting that stimulation of GSH/OA -exchanges enhances the execution phase of apoptosis. These observations were corroborated by single cell immunolabeling analysis by flow cytometry. FasL induced the appearance of a population of cells stained positive against cleaved Anti-caspase3 and Anti-PARP antibodies, which was significantly reduced in the presence of high extracellular GSH ( Figure 8A and 8C ). In addition, the stimulatory effects of MK571 on the cleavage of caspases and their substrates, analyzed by both flow cytometry and western immunoblotting, were fully prevented by the presence of high extracellular GSH ( Figure 8A-D) , supporting the idea that they are mediated by the loss of GSH i .
We finally investigated the effects of GSH transport modulation on FasL induced DNA degradation in Jurkat cells. Figure 9 shows frequency histograms of PI fluorescence showing the DNA content of Jurkat cells. FasL induced the appearance of a subdiploid peak of DNA, indicating the occurrence of degraded DNA (left of the black line). In the presence of high extracellular GSH, DNA degradation was highly reduced. Trans-stimulation of GSH efflux by MK571, however, did not increase the number of cells with degraded DNA. However the observation that high GSH conditions prevent FasL induced DNA degradation supports the hypothesis of the necessary role of a reduction in [GSH] i for the activation of endonucleases. Together, these results suggest that GSH transport through a SLCO/OATP transporter is necessary for the progression of the execution phase of FasLinduced apoptosis.
DISCUSSION
Programmed cell death or apoptosis, is a fundamental process implicated not only in pathophysiological states, but also during the development and normal physiology of organisms (1) . The signaling pathways involved in the progression and activation of apoptosis have been extensively studied and dissected. Despite this, recent reports have discovered new roles for changes in the intracellular milieu of cells during apoptosis, as determinants in the activation of the apoptotic machinery including caspases and endonucleases. For example, it has been reported that changes in the cytosolic environment of cells, like changes in the ionic homeostasis, pH and the redox potential, modulate the progression of the apoptotic program (22, 23, 44) . A reduction in the intracellular concentration of GSH, [GSH] i , is a common feature during apoptosis, but the mechanisms involved in this phenomenon are still far from being understood. Here we report for the first time that the reduction in [GSH] i during FasLinduced apoptosis is mediated by the activation of an efflux mechanism with characteristics of a SLCO/OATP-like transport (a GSH/OA -exchanger). Moreover, we present evidence that GSH transport tightly modulates the progression of the execution phase of apoptosis.
The reduction in GSH i during apoptosis has previously been reported to be associated with the activation of an active efflux transport mechanism. Several studies have demonstrated that reduced glutathione can be recovered from the extracellular medium suggesting that GSH efflux occurs in its reduced, but not its oxidized (GSSG) form (7, 8, 11, 16 ) discarding the role or reactive oxygen species in the reduction of [GSH] i . In this way, we observed that the reduction in GSH i by FasL is due to a total reduction in the [GSH tot ] that does not involve non-specific leakage through plasma membrane. Moreover, we did not detect the formation of intracellular GSSG upon FasL stimulation, discarding the role of intracellular GSH oxidation in GSH depletion. Thus, our results supports previous observations implicating the activation of a plasma membrane transport involved in the extrusion of GSH during apoptosis.
Two types of GSH efflux transporters have been identified at the molecular level. These include the ABCC/MRP and the OATP/SLCO families of organic anion transporters. Previous studies have suggested that ABCC/MRP transporters may be involved in GSH efflux during apoptosis (11, 45) . Glutathione transport mediated by ABCC/MRP has been shown to be involved in the detoxification of the intracellular environment of the cell, and it is coupled to the extrusion of a wide variety of structurally unrelated organic molecules. Drug reversal agents of ABCC/MRP transport inhibit ABCC/MRP transport of organic molecules as well as GSH extrusion (15, (27) (28) (29) (32) (33) (34) . We report that Jurkat cells functionally express ABCC/MRP proteins from which we detect mRNA for several members, particularly ABCC1/MRP-1, ABCC2/MRP-2, ABCC4/MRP-4 and ABCC5/MRP-5. Multidrug resistance protein transport activity was clearly inhibited by the drug reversal agents MK571 and probenecid. However, we observed that these agents stimulate rather than reduce GSH efflux during FasL-induced apoptosis. This effect was unrelated to differences in the expression of the ABCC/MRP proteins because we observe a homogeneous expression of at least the ABCC1/MRP1 in all the population of Jurkat cells. These results contrast with previous reports showing that probenecid inhibits GSH efflux activated by FasL in HepG2 hepatoma cells (7) . Thus, at least in lymphoid cells, GSH extrusion during apoptosis does not seem to be mediated by the ABCC/MRP family of transporters.
The organic anion transporting polypeptides (SLCO/OATP) form a superfamily of sodium-independent transport systems that mediate the transmembrane transport of a wide variety of endogenous and exogenous amphipathic organic compounds. Recent studies have shown that these transporters accept GSH as a substrate in exchange for an organic anion (29, 36, 39) . We report here that Jurkat cells express mRNA for the SLCO3A1/OATP-D, SLCO4A1/OATP-E and SLCO4C1/OATP-H genes. Pharmacological characterization of SCO/OATP transport activity has led to the observation that GSH extrusion can be trans-stimulated by the presence of extracellular organic molecules, including probenecid, and that the major driving force of SLCO/OATP-mediated GSH efflux is the electrochemical gradient of GSH across the plasma membrane (15, 26, 29, (35) (36) (37) (38) (39) (40) . The observation that GSH efflux during FasLinduced apoptosis was trans-stimulated by the MRP inhibitors MK571 and probenecid prompted us to study the role of an SLCO mediated transport in GSH i extrusion activated by FasL. We observed that FasL-induced GSH efflux was also transstimulated by the SLCO/OATP substrates taurocholic acid, estrone sulfate and BSP, further supporting the involvement of a SLCO/OATP-like transport mechanism. Furthermore, reducing the electrochemical gradient of GSH by high extracellular GSH concentration prevented both GSH i loss induced by FasL and its transstimulation by MK571. Accordingly, accumulation of GSH e was shown to be induced by FasL and being stimulated by MK571. Extracellular GSH accumulation was fully prevented by high GSH medium. Together these data argue against the possibility of an ABCC/MRP-like transporter mediating the GSH efflux during FasL-induced apoptosis. It is important to mention that the SLCO/OATP substrates were not able to stimulate GSH efflux in the absence of FasL treatment, unless higher concentrations of at least by a 10 times fold increase, were used (not shown). This suggests that the effect of the organic substrates is on the GSH efflux mechanism activated during apoptosis and not through the activation of a secondary GSH transport.
We also show for the first time that FasL induces the activation of an OA -uptake mechanism that parallels the loss of GSH i , which further supports the role of a GSH/OA -exchanger (SLCO/OATP-like transporter), on GSH depletion during apoptosis. This OA -uptake mechanism seems to be tonically active as evidenced by the observation that there is a significant uptake of CDF in Jurkat cells in the absence of FasL treatment. These results also suggested that FasLinduced apoptosis might induce an increase in the exchange rate of the SLCO/OATP transporter involved, for either the GSH i or for another organic substrate present in the extracellular medium. A more detailed study will be necessary to elucidate the exact molecular identity of the SLCO/OATP involved, the OA -involved in the GSH exchange process and more importantly, the mechanisms involved in its modulation during apoptosis. We cannot rule out the possibility that other mechanisms might be involved in GSH i loss during apoptosis. It is unlikely that GSH depletion during FasL-induced apoptosis is mediated by synthesis inhibition and normal turnover since it was shown to take up to 24hr in the presence of BSO, a specific inhibitor of GSH synthesis. Additionally FasL-induced GSH loss was not modified by BSO. A recent study has shown that glutamate-L-cysteine ligase, the rate limiting enzyme in GSH biosynthesis, is a direct target of caspase 3 (46) . This may represent an additional mechanism for preventing GSH i replenishments during apoptosis.
Although GSH i loss is a common feature during apoptosis, its relationship to the progression of the cell death program has not been clearly established. Interestingly, an apoptosisresistant phenotype has been associated with high intracellular levels of GSH (13, 14, 47, 48) . Previous studies have reported that GSH i loss directly modulates both the permeability transition pore formation, and the activation of caspase 3 (21, (49) (50) (51) (52) (53) . Other reports have proposed that GSH i loss is preceded by the activation of execution caspases (7) . A role of intracellular thiol depletion for the activation of endonucleases in apoptosis has also been previously suggested (54) . We present evidence that GSH transport modulates the activation of the execution phase of apoptosis that includes activation of execution caspases and endonucleases. We also observed that GSH i loss in apoptosis seems to occur in two stages. The high degree of GSH depletion and cell shrinkage suggest that GSH i loss in this stage might be more related to the cell demise and not to an active transport of GSH. These observations underscore the requirement of studying the role of GSH i loss at different stages throughout apoptosis and not as a single event occurring during the apoptotic signaling cascade. In conclusion, we propose for the first time that GSH efflux during apoptosis is mediated by a GSH/OA -exchange transport with characteristics of a SLCO/OATP-like transporter.
This transport modulates the activation of the signaling machinery involved in the execution phase of FasL-induced apoptosis and the further progression of the cell demise.
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* We acknowledge Dr. John Pritchard and Dr. David S. Miller review of this manuscript. We appreciate MS. Maria Sifre, for technical support in the flow cytometry studies, and Dr. Carl D. Bortner's valuable comments regarding the manuscript. We appreciate the National Cancer Institute Fellows Editorial Board for its constructive comments on the manuscript. The research was supported by the Intramural Research Program of the NIH, NIEHS. 1 The abbreviations used are: GSH, reduced glutathione; GSSG, glutathione disulfide; GSH i , intracellular glutathione; GSH e , extracellular GSH; GSSG e , extracellular GSSG; [GSH] i , intracellular glutathione concentration; [GSH tot ], total glutathione concentration (both reduced GSH and oxidized GSSG); FasL, Fas ligand; OA -, organic anion; OA -uptake organic anion uptake. Relative mRNA levels for ABCC/MRP and SLCO/OATP transporters were analyzed using a relative standard curve from 50 to 200ng (5 concentrations) of cDNA input to obtain the threshold cycle, C T . Data is expressed as the intercept C T values (IC T ) of each gene obtained from standard curves normalized against the C T value for GAPDH, i.e. C TGAPDH /C T . As control we used GAPDH, to correct for potential variation in RNA loading of efficiency of the amplification in each experiment. The table shows the standard curve equation for each gene where the logarithm of each cDNA input concentration is plotted on the x-axis and the corresponding C T value on the y-axis. R 2 is calculated from the standard curve of 5 data pairs (0-200ng). C T of > 40, or C T GAPDH / C T values < 0.6, indicates that mRNA levels were on the lower limit of detection. ND means no fluorescent emission signal was detected after 40 cycles. Data are means of 3 experiments ± ES. Table 2 . Extracellular and intracellular determinations of reduced (GSH) and oxidized (GSSG) glutathione. Cells (2 x 10 7 cells/ml) were incubated (4 h) with acivicin (250 µM), and then, stimulated with FasL (100 ng/ml) for 2hr with or without MK571 (50 µM), in the presence or absence of high extracellular GSH concentrations (25mM). Samples were centrifuged and aliquots of the media were taken to determine changes in extracellular ( e ) levels of GSH and GSSG. Pellets were used to asses levels of intracellular ( i ) GSH and GSSG concentrations. Results were normalized against protein concentrations of each sample. The extracellular and intracellular GSH and GSSG concentrations were measured enzymatically using the GSH/GSSG-412 kit (Oxis Research, Portland, OR) according to manufacturer's instructions. Samples were prepared in 5% metaphosphoric acid to remove proteins, with or without 1-methyl-2-vinyl-pyridium trifluoromethane sulfonate, a GSH-specific scavenger. Ellman's reagent (5',5-dithiobis-2-nitrobenzoic acid) reacts with GSH to form a product with an absorption maximum at 412 nm. GSSG was determined using glutathione reductase and β-nicotinamide adenine dinucleotide phosphate (NADPH) to reduce GSSG to GSH followed by reaction with Ellman's reagent. Results are normalized to protein concentration for each sample, and are means of n = 5 ± ES. *p<0.05, against corresponding control values. **p<0.05 against corresponding FasL values. 
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